Thomas Graeber

Thomas Graeber, PhD, is a Professor at the Molecular Biology Institute of the University of California, Los Angeles (UCLA). His research focuses on cancer metabolism, tumor microenvironment dynamics, and metabolic reprogramming across malignancies including glioblastoma, melanoma, and prostate cancer. Recent work demonstrates synthetic lethal interactions in glioblastoma metabolism, neuroendocrine cancer progression mechanisms, and immune-modulatory effects of metabolic interventions.

• Key research themes: Cancer metabolic vulnerabilities, Signal transduction in oncogenesis, Systems biology of tumor heterogeneity
• Recent collaborations: Sarcoma metabolic targeting (2024), Cardiac recovery post-infarction (2024), Melanoma redox protection (2024)

His 15 most recent publications (2022-2025) reveal trends in mitochondrial dependencies, redox signaling, and oncogenic pathway interactions across solid and hematologic cancers. Emerging themes include synthetic lethality, metabolic crisis induction, and cellular plasticity in therapy resistance.